Chris Leahy heads the Global Finance function for Piramal Pharma Solutions (PPS) across North America, Europe and India. In his current role, Mr. Leahy is responsible for long term financial strategy, driving profitable growth for the business as well as financial reporting, analysis and internal controls. He has played an active role in M&A transactions, ensuring high returns on various growth capex investments, and helped secure the private equity investment into PPL in 2020.
Mr. Leahy has been with PPS for over a decade and has previously worked with Price Waterhouse Coopers, ICI and Pfizer where he was a Finance Director at a large manufacturing facility. He is a qualified UK Chartered Accountant with over two decades of experience in the Pharmaceutical industry. His experience in Finance include Audit, Financial Planning and Analysis, Financial Reporting, M&A, Taxation, and Procurement, with a strong commercial focus.
Mr. Leahy holds a BSc (Hons) degree in Mathematics from Bristol University (UK).
